Wellington Management Group LLP Cytokinetics Inc Transaction History
Wellington Management Group LLP
- $557 Billion
- Q3 2024
A detailed history of Wellington Management Group LLP transactions in Cytokinetics Inc stock. As of the latest transaction made, Wellington Management Group LLP holds 7,774,970 shares of CYTK stock, worth $381 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
7,774,970
Previous 7,509,530
3.53%
Holding current value
$381 Million
Previous $407 Million
0.9%
% of portfolio
0.07%
Previous 0.07%
Shares
18 transactions
Others Institutions Holding CYTK
# of Institutions
409Shares Held
125MCall Options Held
4.6MPut Options Held
2.43M-
Black Rock Inc. New York, NY14.7MShares$718 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$576 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.69MShares$474 Million0.31% of portfolio
-
State Street Corp Boston, MA6.46MShares$316 Million0.01% of portfolio
-
Bank Of America Corp Charlotte, NC4.83MShares$236 Million0.02% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.61B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...